Cohlhepp Ryan

CIK 00020346651 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0002034665

Recent Transactions

23 trades

Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-02-02+300,000→ 300,000 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-01-22$18.10/sh−3,828→ 210,164 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-01-15$18.02/sh−149→ 213,992 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-12-15−8,000→ 141,334 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-12-15$3.79/sh+8,000→ 201,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-12-15$18.68/sh−8,000→ 193,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-12-15$18.68/sh−4,500→ 189,141 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-21$18.05/sh−4,500→ 193,641 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-11-21−8,000→ 149,334 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-21$3.79/sh+8,000→ 206,141 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-21$18.05/sh−8,000→ 198,141 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-15$18.16/sh−4,500→ 198,141 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-15$3.79/sh+8,000→ 210,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-15$18.16/sh−8,000→ 202,641 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-15−8,000→ 157,334 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-07$3.79/sh+8,000→ 213,541 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-07$18.06/sh−2,900→ 202,641 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-07$18.06/sh−8,000→ 205,541 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-07−8,000→ 165,334 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-06$18.06/sh−15,600→ 205,541 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-06−24,000→ 173,334 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-06$3.79/sh+24,000→ 245,141 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-06$18.06/sh−24,000→ 221,141 total

Companies

Bicara Therapeutics Inc.
Director, President and COO
$BCAX

Recent Filings

Address

BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703

BOSTON, MA, 02116

View on SEC.gov